Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M (2016) Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of long term, multicentre, doubled blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 352:h6816
Baloh RW (2003) Clinical practice. Vestibular neuritis. N Engl J Med 348:1027–1032
Billio A, Morello E, Clarke MJ (2010) (2010): Serotonin receptor antagonists for highly emetogenic chemotherapy in adults. Cochrane Database Syst Rev 2010 Jan 20; (1): CD006272
Brandt T, Dichgans J, Diener HC (Hrsg) (1998) Therapie und Verlauf neurologischer Erkrankungen, 3. Aufl. Verlag Kohlhammer, Stuttgart Berlin Köln, S 127–156
Hamann K-F, Arnold W (1999): Menière’s disease. In: Büttner U (ed): Vestibular dysfunction and its therapy. Adv ORL 55: 137–168.
Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M, Canis M (2012) Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS ONE 7:e39086
James A, Burton MJ (2009): Betahistine for Ménière’s disease or syndrome. Cochrane Database of Systematic Reviews 2001, Issue 1. Publication status and date: Edited (no change to conclusions), published in Issue 1, 2009. Art. No.: CD001873. DOI: https://doi.org/10.1002/14651858.CD001873.
Kranke P, Morin AM, Roewer N, Eberhart LH (2002) Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesthesiol Scand 46:238–244
Lacour M, van de Heyning PH, Novotny M, Tighilet B (2007) Betahistine in the treatment of Ménière’s disease. Neuropsychiatr Dis Treat 3:441–453
Molino A, Guglielmo L, Azzolini ME, Biondani P, Capelli MC, Grandinetti A, Griso C, Martinelli G, Martini N, Zanotti R et al (1991) The antiemetic activity of high-dose metoclopramide and high-dose alizapride in combination with lorazepam in patients receiving cancer chemotherapy. A prospective, randomized, double-blind study. Oncology 48:111–115
Spinks AB, Wasiak J, Villanueva EV, Bernath V (2007) Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane Database Syst Rev 2007 Jul 18; (3): CE002851
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Hamann, KF. (2019). Antiemetika und Antivertiginosa. In: Schwabe, U., Paffrath, D., Ludwig, WD., Klauber, J. (eds) Arzneiverordnungs-Report 2019. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59046-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-662-59046-1_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-59045-4
Online ISBN: 978-3-662-59046-1
eBook Packages: Medicine (German Language)